| AINIX | OAZIX | AINIX / OAZIX | |
| Total Expense Ratio | 0.91 | 0.75 | 121% |
| Annual Report Gross Expense Ratio | 1.01 | 0.75 | 135% |
| Fund Existence | 14 years | 5 years | - |
| Gain YTD | 1.403 | 3.612 | 39% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 264M | 14.5B | 2% |
| Annual Yield % from dividends | 2.26 | 2.18 | 104% |
| Returns for 1 year | 19.15 | 40.55 | 47% |
| Returns for 3 years | 28.66 | 40.83 | 70% |
| Returns for 5 years | 23.35 | 37.37 | 62% |
| Returns for 10 years | 65.73 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ERHSX | 14.95 | 0.12 | +0.81% |
| Eaton Vance Worldwide Health Sci R | |||
| OSCCX | 20.89 | 0.09 | +0.43% |
| Invesco Main Street Small Cap C | |||
| GPEIX | 10.30 | 0.03 | +0.29% |
| Grandeur Peak Emerg Mkts Opps Instl | |||
| ANVIX | 27.04 | N/A | N/A |
| Virtus NFJ Large-Cap Value Fund Inst | |||
| JMGZX | 44.12 | -0.23 | -0.52% |
| JPMorgan Mid Cap Growth R2 | |||